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 Arterial spin labeling (ASL) is a magnetic resonance imaging (MRI) technique 
used for measuring cerebral blood flow (CBF) in a completely non-ionizing and non-
invasive fashion. ASL is useful in perfusion studies on healthy adult & pediatric subjects, 
individuals who need multiple follow-ups, and patients with varying cerebrovascular 
diseases where changes in CBF can be used as an indicator of tissue viability. We used a 
variation of the ASL technique known as pseudo-continuous ASL (pCASL). This form of 
ASL is the clinical standard (Alsop et al., 2015). However, it is not well documented the 
that pCASL is reliable between sessions spanning days to weeks. In this study, we 
assessed the inter-session reliability of CBF through the use of the pCASL technique. We 
hypothesize that the pCASL technique can be used to quantify CBF measurements across 
a 24-hour and 48-hour period.  
 Subjects included 15 healthy, active duty Air Force military personnel recruited 
by the Wright Patterson Air Force Base from a larger experiment. Of the 15 subjects 
scanned on day 1 and day 2, 2 did not return for scanning on the third day. All 
participants were scanned in three identical evening sessions separated by 24 hours. MR 
imaging was conducted on a 3T MRI scanner with a 24-channel head coil. Each of the 
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three days began with a baseline imaging scan followed by sham transcranial direct 
current stimulation (tDCS) and another identical imaging session. MRI acquisition 
included a 12-min resting-state function MRI (fMRI), three task fMRI, a T1-weighted 
MRI, diffusion tensor imaging (DTI), magnetic resonance spectroscopy (MRS) imaging, 
and resting pCASL. Our work only shows the baseline imaging from each day and the 
resting pCASL results. Quantitative CBF maps were computed from the raw pCASL data 
using proton density maps and a single compartment perfusion model through the use of 
the clinical processing pipeline on the MRI. These CBF maps were then registered to a 
reference space. Changes in CBF between the three pre-sham stimulation days were 
analyzed on a voxel-wise basis through a one-sample t-test and permutation testing using 
215 (32,768) permutations for the difference between day 1 and day 2 and 213 (8192) 
permutations for the difference between day 1 and day 3 and day 2 and day 3. 
Permutation test results were not cluster-corrected for multiple comparisons to be 
conservative with respect to our hypothesis but were thresholded with a t-statistic of 2.3. 
The experiment’s results indicated that the pCASL MRI technique can indeed be used 
reliably in radiological evaluation to quantitatively assess CBF within a 24-hour but not 
quite in a 48-hour periods. 
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I. INTRODUCTION AND PURPOSE 
 
The human body cannot survive without receiving a constant stream of nutrients 
delivered to every single organ. The brain, being arguably the most important organ in 
the human body, is especially in need of a continuous flow of nutrients. Cerebral 
perfusion is the mechanism responsible for the delivery of different nutrients and oxygen 
to tissues of the brain. It is a fundamental physiological parameter that has been found to 
be linked to direct tissue function, and perfusion disorders are the leading causes of 
medical mortality and morbidity (Detre, Rao, Wang, Chen, & Wang, 2012). There is a 
wide variety of different techniques used to measure perfusion through an exogenously 
administered tracer. The first tracer used in magnetic resonance imaging (MRI) was 
deuterated water (deuterium oxide), a non-radiative isotope available commercially as 
2H2O (Ackerman, Ewy, Becker, & Shalwitz, 2006). Trifluoromethane was also used as 
well as hyperpolarized tracers. In positron emission tomography (PET), the flow tracer 
used is radioactive 15O labeled water. 
Amongst the many different MRI methods measuring cerebral blood flow (CBF) 
existing today, arterial spin labeling (ASL) does not require an injected tracer and has the 
best spatial and temporal resolution (Buxton, 2009). ASL is also a completely non-
invasive and non-ionizing MRI technique for calculating tissue perfusion in the brain. 
This makes ASL particularly useful in perfusion studies on healthy subjects, individuals 
who need several follow-ups, and pediatric patients, where the use of exogenous contrast 
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agents and radioactive tracers is regulated (Petcharunpaisan, 2010). In a study conducted 
on children with sickle cell anemia, ASL was used to show a large true increase in CBF 
in all cerebral arterial territories, which fell in line with previously conducted PET results 
(Oguz et al., 2003). ASL also offers the benefit of being quantitative, unlike conservative 
bolus techniques. This permits the identification of global hyper- or hypo- perfusion 
conditions and allows comparison between numerous measurements in a longitudinal 
study (Deibler et al., 2008; Petcharunpaisan, 2010). 
A. Goal of ASL 
 
The goal of ASL is to measure the rate of arterial blood delivered to a brain voxel in 
the sliced image of interest through the production of a control image and a tagged image 
with indistinguishable tissue signals but differing magnetization of the inflowing blood 
(Buxton, 2009; Petcharunpaisan, 2010). This technique measures perfusion through the 
non-invasive labeling of water spins in arterial blood before it enters tissue of interest.  A 
180° radio frequency inversion pulse flips the magnetization of the arterial blood’s water 
protons before they reach the sliced image as seen in Figure 1. After a delay, known as 
the inversion time (TI), the magnetized labeled molecules of water then enter the tissue 
proportionally with CBF where the slice of interest, the tagged image (labeled image), is 





Figure 1 - Basic Principle for ASL acquisition (J. C. Ferré et al., 2013). The red 
indicated the area where labeling will take place. The yellow arrows are meant to 
show the labeled blood entering the brain. The blue region is where imaging will 
take place. 
 The process is then repeated a second time where the arterial blood is not labeled to 
produce a control image. Finally, the two images are then subtracted to create the ASL 
difference image. The desired result is for the signals from unlabeled static spins to 
cancel out from each other, leaving only the signal difference. Thus, the ASL difference 
image signal is in direct proportion to the amount of arterial blood that was transported in 





Figure 2 - General principle of ASL showing image subtraction, adapted from: (J. 
C. Ferré et al., 2013). The red indicates the region where the labeling of the blood 
will take place and the blue is where image acquisition will occur.  
B. Quantification of CBF 
 
 The Bloch equations are a series of macroscopic equations that describe tissue 
magnetization Mb(t) when inflowing spins are present (Williams, Detre, Leigh, & 
Koretsky, 2006). They are used to determine the nuclear Magnetization (M) as a function 
of time while relaxation times are present. ASL theory is based upon these equations. 
Quantification of CBF in ASL is dependent on subtracting the labeled image from the 
control image each obtained with differing states of arterial blood magnetization in order 
to provide a perfusion-weighted image (ΔM) (Duhamel, Callot, Tachrount, Alsop, & 
Cozzone, 2012). The connection amongst CBF and ΔM is dependent on factors such as 
the labeled tissue’s relaxation time (T1), the tissue’s proton density, and the difference 
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between the two (J. C. Ferré et al., 2013). The travel time between the labeled area and 
the volume of importance is also an important factor (J. C. Ferré et al., 2013).  
 In the model used to quantify CBF, there are three major assumptions; First, we 
assume that the entire labeled bolus of blood is delivered to its target tissue. Second, we 
assume that no labeled blood water will outflow during delivery. Finally, we adopt the 
assumption that the relaxation of our labeled spins are governed by the blood T1 (Alsop et 
al., 2015). This assumption is not expected to be completely true but the errors produced 
by the variations are very small. Under said assumptions, CBF in each voxel could be 
quantified for pCASL using the following equation (Alsop et al., 2015):  
  𝐶𝐵𝐹 =  
6000 ∙ λ ∙(𝑆𝐼𝑐𝑜𝑛𝑡𝑟𝑜𝑙− 𝑆𝐼𝑙𝑎𝑏𝑒𝑙) ∙  
𝑃𝐿𝐷
𝑒T1 blood 




 [ml /100g /min] 
 
In the equation above, 𝜆 is the blood/brain barrier coefficient in mL/g, SIlabel and SIcontrol 
are the time-averaged signal strengths in the label and control images, respectively, T1 
blood is the blood relaxation time in seconds, 𝛼 is the ASL labeling efficiency, 𝜏 is the 
duration of the label, PLD is the post labeling delay, TI in pCASL is the same as PLD, 
TI1 is 800ms, and SIPD is the proton density-weighted images signal intensity. 
 CBF can be quantified in vivo through a non-invasive method using an MRI 
machine and an ASL pulse sequence. Multiple assumed values are typically used for 
factors such as labeling efficiency, arterial transit time, capillary permeability to water, 
and magnetization transfer effects. It is preferred to use assumed values since measuring 
them for each participant can cause added noise to the CBF maps (Detre et al., 2012). 
Measuring individual values is also an extremely time consuming task. Major sources of 
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inaccuracy in CBF quantification in this method come from differences in arterial transit 
time, blood T1 relaxation, and labeling efficiencies. Today, we use more advanced signal 
processing schemes already coded in the MRI’s image acquisition software as well as 
improved characterization of compartmentalization in ASL to produce more reliable 
quantifications of cerebral perfusion. Further advances in the ASL technique’s ability to 
quantify CBF appear to be very promising.  
C. Types of ASL 
 
Arterial Spin labeling is commonly accomplished by either continuous inversion of 
the magnetization of the blood flow at a particular plane (continuous ASL [CASL]), or by 
a single short radiofrequency (RF) (pulsed ASL [PASL]) that inverts a specific volume of 
blood (Duhamel et al., 2012). In CASL, long and uninterrupted RF pulses (1 – 4 s) are 
used with a slice-selective gradient on a plane near the sliced images to generate a flow-
driven adiabatic inversion (Wu, Fernández-Seara, Detre, Wehrli, & Wang, 2007). Flow-
driven adiabatic inversion is a process where the spins are inverted in a physiological set 
of velocities flowing perpendicular to the tagging region by shifting the RF pulse and 
amplitudes of the gradients (Petcharunpaisan, 2010). The longer stable state tagging with 
continuously inverted spins provides a higher theoretical signal-to-noise ratio (SNR) than 
PASL. However, the tagging efficiency of CASL may be affected by the variations in 
flow velocity, making the tagging efficiency an average of (80% - 95%), and even as low 
as 68% when using an amplitude-modulated (AM) control (Wu et al., 2007). Another 
drawback of the CASL technique’s clinical use is the necessity for hardware with 
continuous RF transmission which is not commonly available in clinical settings (Pollock 
et al., 2009).  
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In PASL, rather than labeling the blood as it flows through a section, an instantaneous 
RF pulse (5 to 20 ms) is used to tag a thick slab of arterial blood known as the tagging 
region which is proximal to the imaging region. The execution is straight forward and 
gives an average tagging efficiency of over 95%, and has been seen to be generally 
insensitive to change in flow velocity (Wu et al., 2007). The lower amount of practical 
problems and simplicity of implementation in comparison to CASL have made PASL the 
preferred choice of the two for perfusion imaging in clinical settings.   
Most recently, due to technical limitations of CASL, pseudocontinuous ASL 
(pCASL) has been introduced as an intermediary method that takes advantage of CASL’s 
higher SNR and PASL’s tagging efficiency (Wu et al., 2007). This method uses a train of 
discrete RF pulses with a gradient wave set between two successive RF pulses which 
imitate CASL’s method of flow-driven inversion (Petcharunpaisan, 2010).  
D. ASL Specific Artifacts  
 
Artifacts are abnormalities that appear during imaging that disturb the ability to 
accurately assess CBF. There are a few different kinds of artifacts that can be seen when 
using ASL imaging techniques. Vascular artifacts are essentially hyper-signals located in 
the arterial or venous structures, and in the deep or juxtacortical structures. Labeled 
protons within the vessels are associated with these vascular artifacts (J. C. Ferré et al., 
2013). For instance, if the inversion time chosen is not high enough, or the transit time is 
too high (e.g. in severe carotid stenosis) the tagged blood will be found in the arteries as 
it will not have enough time to reach the capillaries. In order to help reduce the hyper-
signal from the vessels in a uniform manner, crushers can be added. Crushers are bipolar 
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gradients set in multiple directions just before and during the acquisition of ASL images 
to remove the rapid flow (Ye et al., 1997).  
Another type of artifact occurs in areas of hyper-perfusion and hypo-perfusion and is 
connected to physiological modification of perfusion. The occipital region, for example, 
tends to be an area of hyper-perfusion due to the activation of the brain’s visual areas in 
the MRI surroundings (Deibler et al., 2008). Areas of hypo-perfusion spread from frontal 
and parieto-occipital cortex to the frontal and occipital horns (Hendrikse, Petersen, van 
Laar, & Golay, 2008). This may be due to the difficulty of getting a reliable CBF 
measurement in brain white matter (J. C. Ferré et al., 2013).  
Magnetic susceptibility artifacts can occur when attempting to rapidly acquire images 
during scanning and can be seen as a focal decrease in perfusion in the frontal region, 
temporal region, and the base of the skull (J. C. Ferré et al., 2013). One way to reduce 
magnetic susceptibility artifacts is to use less sensitive means of image acquisition such 
as parallel imaging (Jean Christophe Ferré, Petr, Bannier, Barillot, & Gauvrit, 2012) 
As ASL is a subtraction method, it has been shown to be sensitive to patient 
movements. The numerous repetitions needed to acquire a reasonable SNR cause the 
sequence to have increased sensitivity to movement artifacts (J. C. Ferré et al., 2013). 
Images overly subjected to movements during scanning are commonly excluded from 
analysis. There have been filters developed and implemented to identify and remove poor 
subtraction pairs caused by larger movements (Petcharunpaisan, 2010).  




ASL is predominantly used in the fields of neuroscience and neurology in the study 
and evaluation of the brain, and has only rarely been applied to the rest of the body. 
Commercial ASL sequences today are found in almost all major MRI Clinical platforms. 
This makes it possible for ASL to be added to standard clinical imaging protocols.  
 A primary application of ASL is in the study of cerebrovascular diseases, where CBF 
is used as an indicator of tissue viability. The most prevalent fundamental source of all 
ischemic strokes and the indicator of recurrent strokes for example, is diminished 
cerebral perfusion (Detre et al., 1998). Tissue that can be potentially saved with quick re-
perfusion, such as ischemic penumbra (penumbra is a tissue area with reduced perfusion 
with no restricted diffusions), can be identified and saved through the use of ASL 
perfusion imaging (Harris, Coutts, & Frayne, 2009).   
Studies have demonstrated that ASL can be used in both pediatric and adult 
populations with acute stroke cases (J. Chen et al., 2009).  ASL techniques can be used to 
represent areas of hemispheric or focal perfusion deficits, post-ischemic hyper-perfusion 
or perfusion-diffusion mismatches (J. Chen et al., 2009). It was found that there were 
agreements between traditional MRI, magnetic resonance angiography (MRA) and ASL 
perfusion maps (J. Chen et al., 2009). ASL has also been a proven method in identifying 
diffusion shortages in people with a history of significant extra-cranial carotid artery 
stenosis or transient ischemic attacks (Detre et al., 1998). Studies conducted on healthy 
cerebral tissues have shown that dynamic susceptibility contrast (DSC) magnetic 
resonance (MR) perfusion (a clinically approved method) and ASL both produce 
equivalent results. In one study (Zaharchuk et al., 2009), ASL showed greater 
10 
 
irregularities in patients who have normal DSC perfusion because of ASL’s increased 
sensitivity to extended arterial arrival times.    
ASL can clinically be used to specify the grade of a particular tumor, heterogeneity of 
a tumor, to specify stereotactic biopsy sites in there most malignant portions, and can 
measure the effects of antiangiogenic therapy on tumors (Noguchi et al., 2008). Studies 
have shown that ASL and DSC perfusion are analogous for distinguishing between lower 
grade (I & II) and higher grade (III & IV) glioma  (Wolf & Detre, 2007). DSC and ASL 
perfusion imaging have also shown a strong correlation for determining relative tumor 
blood flow (rTBF) (Noguchi et al., 2008). Qualitative clinical interpretations have shown 
that higher grade brain tumors typically have elevated perfusion on ASL maps, where 
low grade tumors typically display hypo-perfusion (Petcharunpaisan, 2010). 
Imaging techniques are becoming progressively more important in dementia and 
cognitive disorders. They can be used for disease progression observation, differential 
diagnosis, and as alternative markers in treatment trials (Du et al., 2006). The MRI 
techniques used for these purposes include PET, Blood Level Oxygen Dependent 
(BOLD) functional MRI (fMRI), Single Photon Emission Computed Tomography 
(SPECT), diffusion tensor imaging and MR perfusion (Wolf & Detre, 2007). BOLD is 
the standard method for mapping activation patterns in adult’s healthy brain. Blood 
releases oxygen to active neurons at a higher rate than inactive neurons through a process 
known as the hemodynamic response. The BOLD technique identifies these changes 
through their differential magnetic susceptibility.  
 Several studies have shown the ability of ASL to detect mild cognitive impairment 
(MCI) through perfusion mapping in brain areas of focus, regional hypo-perfusion in 
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frontotemporal dementia (FTD), and Alzheimer’s disease (AD), consistent with PET and 
SPECT findings (Du et al., 2006). The PET technique closely parallels ASL perfusion in 
how it works, with the primary exception of the tracer used. The PET technique uses an 
invasively injected radioactive tracer of O15-H2O, where ASL only labels water 
molecules already in the blood magnetically and non-invasively.  ASL perfusion imaging 
techniques can also be used to predict decline in cognitive ability and conversion from 
mild cognitive impairment (MCI) to full dementia and could be useful for finding 
potential applicants for AD treatment trials (Chao et al., 2010).  
F. Purpose & Hypothesis  
 
 The purpose of this study is to evaluate the test-retest inter-session reliability of 
the pCASL technique in the quantification of CBF. Our hypothesis is that the pCASL 
technique can be used as a reliable technique to quantify CBF measurements over a 24-
hour and 48-hour period. Various studies have shown ASL perfusion imaging is indeed 
comparable with other similar methods that are more invasive and have greater risks such 
as DSC MRI perfusion and PET, making ASL the more likely accepted perfusion 
imaging method of the future (Du et al., 2006). 
 In order to determine the full performance capabilities and viability of the pCASL 
technique, we evaluated its reproducibility on a group of healthy volunteers. Given the 
great potential of ASL’s use in clinical and research studies, it is critical that it can 
produce a consistently reliable quantification of CBF in order to properly study 
abnormalities in the brain. Similar studies have tested the inter-session reliability of ASL 
before (Y. Chen, Wang, & Detre, 2011; Fazlollahi et al., 2015; Gevers, Majoie, Van Den 
Tweel, Lavini, & Nederveen, 2009; Wang et al., 2011; Wu, Jiang, Yang, & Lien, 2011). 
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 If we were to demonstrate that pCASL provides reliable consistent results 
between sessions, it can be clinically applied in standard protocol imaging of patients 
with various neurological disorders. ASL would be the more preferred technique as it is 
completely non-invasive and non-ionizing unlike other comparable techniques. For 
instance, it could potentially be used as the standard for routine checkup and monitoring 
of patients with brain tumors or those with cognitive impairments. CBF maps from ASL 
imaging could detect any changes in neurologic conditions, which could indicate whether 
a treatment was successful or not or if there is a need for surgical intervention.  
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 A cohort of fifteen subjects were selected from the sham group of a larger, on-
going study. Of the 15 subjects scanned on day 1 and day 2, 2 did not return for scanning 
on the third day. The subjects were active duty Air Force military personnel recruited 
from the Wright-Patterson Air Force Base. Participants were removed from the study if 
they were currently taking any medicine that could potentially influence cognitive 
function or if they were reliant on nicotine, alcohol or caffeine. Subjects of this study 
were also disqualified from partaking if they had any hearing, vision, or motor control 
problems; psychological or neurological diagnoses; or any recent hospitalization or 
trauma. Participants were provided informed written consent before any experimental 
procedures took place. These procedures were sanctioned by Air Force Laboratory 
Institution Review Board (Protocol # FWR20130126H). The participants who qualified 
for payment (e.g. if involvement transpired while off-duty) were given equal 
imbursement.  
 In the larger study, participants were either assigned to an experimental group or a 
sham group. The same instructions and tasks were provided to both groups with the 
exclusion of the stimulation administered to each. The stimulation the experimental group 
received was 2 mA transcranial direct current stimulation (tDCS) applied to the left 
prefrontal cortex for a duration of 30 minutes; the sham group (n=15, mean age 25.9 ± 
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3.2, 3 females) received a stimulation of 2 mA applied to the left prefrontal cortex for 
only 30 seconds. Members of both groups were blinded to the legitimacy of the 
stimulation and were not informed as to when the stimulation would end.  
 Participants of both groups completed the three experimental sessions on three 
days consecutively. However, in our analysis we will only be using the data from the 
sham group for the first session sessions from each of the three days to test inter-session 
reliability. The sessions were performed in the evenings in order to satisfy not only 
subject availability but also MRI availability. Subjects preformed the sessions in groups 
of two with scattered starting times. The start times were consistent across sessions.   
B. Transcranial Direct Current Stimulation 
 
 In all three sessions, an anode was placed on the left prefrontal cortex and a 
cathode was place on the contralateral bicep. As the subject was stimulated, they 
completed a 30 minute laboratory vigilance task (Mackworth, 2008). A constant 2 mA 
electrical stimulation (MagStim Direct Current Stimulator, MagStim Company Limited) 
was administered through a five ring custom NA/NaCl electrode arranged in a 1.6cm 
radius circle, with each outer edge 0.1cm away from another. The cathode location also 
used the same ring arrangement. The 2 mA electrical stimulation was split evenly to each 
of the five electrodes.  Continuous current levels were delivered to the anode through a 
battery-powered stimulator that uses multistage current monitoring. Each of the 
electrodes was placed in small “cup” filled with extremely conductive gel (SignaGel, 
Parker Laboratories) that allows the current to transfer to the scalp and attached to the 
subjects with medical bandages. Again, the sham group only received 30 seconds of 
15 
 
stimulation. Our study was not testing for anything related to said stimulation, however it 
was being used for other purposes in the larger study this data was taken from.   
C. MRI Acquisition  
 During each session, data from the MRI was obtained before and approximately 
half an hour after the application of tDCS. MRI acquisition took place in the following 
arrangement: a 12-minute resting state function MRI (fMRI), three 10-minute fMRI 
tasks, a T1-weighted MRI, diffusion tensor imaging (DTI) of the brain, magnetic 
resonance spectroscopy (MRS) imaging, and resting ASL. We will only be presenting the 
resting ASL data for this study. Also, we would just like to mention subjects completed a 
dual n-back test during the three task fMRIs (Sherwood, Madaris, Mullenger, & 
McKinley, 2018).  
 T1-weighted structural images were obtained through the use of a 3D brain 
volume imaging pulse sequence (BRAVO) that utilized an inversion recovery prepared 
fast spoiled gradient-echo (FSPGR). The structural images were obtained using a 2562 
element matrix, 172 slices aligned to the the posterior commissure- (PC) anterior 
commissure (AC) plane, 1 mm3 isotropic voxels, 0.8 phase field of vision factor, echo 
time (TE) = 3.22 ms, an inversion time (TI) of 450 ms, a flip angle of 13°, and an auto-
calibrated reconstruction for Cartesian sampling that has a phase acceleration factor of 1 
for only the first session and 2 for all other sessions (Sherwood et al., 2018). For all MRI 
procedures we used a 3 Tesla MRI (Discovery 750w, GE Healthcare) with a 24-channel 
head coil. 
 The pseudo-continuous arterial spin labeling (pCASL) method was used to 
acquire images of cerebral perfusion about 20 minutes before the start of tDCS. Inversion 
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tagging pulses ran directly inferior to the brain imaging volume (Silva & Kim, 1999). The 
images were attained oriented perpendicular to the scanner bore, in true axial position, 
while using a post-label delay (PLD) time of 2025 ms. During imaging, a series of five 
background suppression pulses were used to diminish the signal from the stationary 
tissues and increase the signal-to-noise ratio (SNR) of the inflowing arterial blood (Mani, 
Pauly, Conolly, Meyer, & Nishimura, 1997; Ye, Frank, Weinberger, & McLaughlin, 
2000). The imaging volume was acquired using a 3D fast spin echo sequence. A stack-of-
spirals readout time gradient that began at the midpoint of the k-space was used to 
decrease sensitivity to motion, minimalize any susceptibility artifacts, and improve 
overall acquisition time (Kim, Adalsteinsson, & Spielman, 2003). The k-space sampling 
used a sum of eight spiral arms. The echoes were re-binned to Cartesian space in a 1282 
matrix, voxel size = 1.875 mm2, TE = 10.7 ms, repetition time (TR) = 4640ms, flip angle 
= 111°, slice thickness set at 4 mm, and a total acquisition time of 4 minutes 46 seconds. 
Subjects were asked to stay awake and keep their focus on a small dot fixed on the screen 
in front of them during the scan period. This method has been implemented to 
considerably increase reliability in resting-state fMRI over auditory networks, attention, 
and all within-network connections when compared to the eyes closed method or open 
eyes with no specific fixation point (Patriat et al., 2013), and was implemented here to 
attempt to do the same. 
D. Analysis & Data Processing 
 
 The pCASL technique was used to quantify cerebral perfusion. The GE 
reconstruction software’s automated functions were used to compute CBF maps from the 
scans. Initially, the average of the 2 tagged images and the 2 control images was taken 
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without correction for motion. Next, the average tagged volumes were subtracted from 
the average control volumes in order to calculate a difference image. Lastly, the 
difference image, a standard single compartment model, and the connected proton 
density-weighted volumes were used to produce the quantitative CBF maps (Alsop et al., 
2015; Sherwood et al., 2018).  
 The generated CBF maps from each session and day were transferred from the 
MRI machine and processed with the FMRIB Software Library (FSL) (Woolrich et al., 
2009) using a Rocks Cluster Distribution high performance computing system powerful 
enough to run 256 threads in parallel. We first registered the proton density-weighted 
images to each subject’s high resolution structural image using a boundary based 
registration method to estimate for motion. This method also included a fieldmap-based 
distortion correction to each image (Greve & Fischl, 2009). We used a 12-parameter 
model and the MNI-152 T1 weighted 2mm template available in FSL to register each 
subject’s high resolution structural image (Jenkinson, Bannister, Brady, & Smith, 2002; 
Mazziotta et al., 2001). The CBF maps were then adapted to standard space to co-register 
all volumes. They were converted using the same transforms accountable for converting 
the proton density weighted image of the data sets to the previous structural image.  
 We then performed a non-parametric statistical analysis on the day 1, session 1 
pre-stimulation and day 2, session 1 pre-stimulation CBF maps in a voxel-wise approach. 
We also did the same in comparing day 1, session 1 pre-stimulation and day 3, session 1 
pre-stimulation as well as day 2, session 1 pre-stimulation and day 3, session 1 pre-
stimulation. In this analysis, we found the statistical significance of the differences in 
CBF, which is determined as the increase in cerebral perfusion from each of the two 
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images compared. This was accomplished through the use of permutation testing using 
FSL Randomise (Winkler, Ridgway, Webster, Smith, & Nichols, 2014). We performed a 
one-sample t-test and permutation testing using 215 (32,768) random permutations for the 
difference between day 1 and day 2 and 213 (8192) permutations for the difference 
between day 1 and day 3 and day 2 and day 3 in order to develop the null t-distribution 
for the contrasts representative of our main effect of each session (Nichols & Holmes, 
2003). Then a t-statistic was computed for each voxel through computing the chance of 
surpassing the known arrangement’s t-statistic value. The permutation test results were 
not cluster-corrected for multiple comparisons in order to be conservative in reference to 















 A sample of the CBF maps produced from the pCASL pulse sequence for a single 
subject across three days can be seen in Figure 3. The results of the registration of the 
CBF maps to standard space for the same subject can be viewed in Figure 4. 
 
Figure 3 – Sample CBF maps in different slices from a single subject for (A) 




Figure 4 – Sample CBF maps following registration to standard space from the 
same subject as Figure 3 registered to standard space for (A) day 1, (B) day 2 and 
(C) day 3. Axial images are from MNI coordinates: z = 2mm, 28mm, 35mm, 
55mm and 70mm (from left to right). 
 Our permutation testing indicated numerous scattered and particularly small 
clusters with significant changes in CBF between day 1 and day 2. Clusters were 
thresholded with a t-statistic of 2.3 and correction for family-wise error was not 
conducted. The cluster with statistical significance for day 2 minus day 1 (negative, 2<1) 
can be seen in Figure 5. The inverse positive change can be seen in Figure 6.  ∆CBF 
maps masked by significant clusters from Figure 5 & 6 can be seen in Figures 7 & 8 
respectively averaged from across all subjects. 




Figure 5 – Clusters with significant decreased perfusion from day 1 to day 2 
(displayed as day 2 minus day 1). Axial slices from the inferior of the brain start 
in the top left of the figure and move superiorly through the brain moving to the 
right and down of the figure. The green circles highlight the largest cluster found 





Figure 6 – Clusters with significant increased perfusion from day 1 to day 2 







Figure 7 – Average decrease in CBF from day 1 to day 2 (displayed as day 2 
minus day 1) for the significant voxels identified in Figure 5 averaged from all 
15 subjects. The green circles highlight the largest cluster found in the left 




Figure 8 – Average increase in CBF from day 1 to day 2 (displayed as day 2 
minus day 1) for the significant voxels identified in Figure 6 averaged from all 
15 subjects. 
We will also be presenting tables detailing the significant clusters found from our study. 
Of the clusters with significant decrease in perfusion from day 1 to day 2 (displayed as 
day 2 minus day 1), the largest appeared outside the brain with a volume of 4.00 cm3. The 
remaining clusters found were smaller than 2.76 cm3, of which, only less than half were 
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within the brain. The largest cluster within the brain appeared in the left superior 
temporal gyrus with a volume of 2.33 cm3 as can be seen in Figures 5 & 7 circled in 
green. Table 1 indicates the location and size of significant clusters located (with none 
smaller than a size of 1.00 cm3) for the decrease from day 1 to day 2. No clusters were 
found larger than 1.00 cm3 for the positive inverse difference. Remaining clusters found 
within the brain with a size greater than 100mm3 are supplied in Appendix A.  
Table 1: Clusters identified with significant decreases in perfusion from pre-
stimulation at day 1 to day 2. Blank spaces in the chart indicate clusters located 
outside of the brain. ∆CBF represents the decrease from day 1 to day 2 and was 
computed as day 2 minus day 1. 













      4000 4.59 -9.4 -19.6 
      2760 4.22 -10.77 -17.4 
Left Temporal Superior Temporal 2328 3.65 -9.38 -15.53 
Right Frontal Rectal  1976 5.2 -17.81 -31.27 
Left Occipital Lingual 1896 3.53 -9.56 -13.53 
      1888 5.29 -15 -26.4 
      1816 3.91 -11.1 -17 
Right Frontal Superior Frontal 1592 3.46 -8.29 -10.87 
      1288 4.34 -9.47 -13.47 
      1208 4.38 -12.85 -21.67 
Left Occiptal  Fusiform 1160 3.2 -9.48 -13.87 




 The clusters with statistical significance for day 3 minus day 1 (negative, 3<1) can 
be seen in Figure 9. The inverse positive change can be seen in Figure 10.  ∆CBF maps 
masked by significant clusters from Figure 9 & 10 can be seen in Figures 11 & 12 
respectively averaged from across all subjects. 
 
Figure 9 – Clusters with significant decreased perfusion from day 1 to day 3 
(displayed as day 3 minus day 1). The green circles highlight the largest cluster 




Figure 10 – Clusters with significant increased perfusion from day 1 to day 3 







Figure 11 – Average decrease in CBF from day 1 to day 3 (displayed as day 3 
minus day 1) for the significant voxels identified in Figure 9 averaged from all 13 





Figure 12 – Average increase in CBF from day 1 to day 3 (displayed as day 3 
minus day 1) for the significant voxels identified in Figure 10 averaged from all 
13 subjects.  
 For the clusters found with significant decrease in perfusion from day 1 to day 3 
(displayed as day 3 minus day 1), the largest appeared in the left lingual gyrus with a 
volume of 15.45 cm3 as can be seen in Figures 9 & 11 circled in green. Two other 
considerably larger clusters were found with volumes of 14.06 cm3 and 12.54 cm3 found 
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in the left superior temporal gyrus and the right insula respectively. The remaining 
clusters found were smaller than 5.37 cm3, of which approximately two thirds were 
within the brain. Table 2 indicates the location and size of significant clusters located 
(with none smaller than a size of 1.00 cm3) for the decrease from day 1 to day 3. Three 
cluster were found larger than 1.00 cm3 for the positive inverse difference as can be seen 
in table 3. All three of which are located outside of the brain. Remaining clusters found in 
the brain with a size greater than 100mm3 are supplied in Appendix A. 
Table 2: Clusters identified with significant decreases in perfusion from pre-
stimulation at day 1 to day 3. Blank spaces in the chart indicate clusters located 
outside of the brain. ∆CBF represents the decrease from day 1 to day 3 and was 
computed as day 3 minus day 1. 
















Left Occipital Lingual 15448 4.44 -7.51 -11.85 
Left Temporal Superior Temporal 14064 4.4 -9.17 -19.46 
Right  Sub-lubar Insula 12536 4.53 -8.55 -14.15 
Left Anterior Culmen 5368 4.05 -8.77 -15.77 
Right  Sub-lubar Insula 2656 3.75 -7.28 -10.54 
   1624 5.87 -11.35 -24.54 
   1496 3.7 -14.03 -20.92 
Right Occipital Cuneus 1448 3.63 -6.73 -8.92 
   1288 4.36 -11.28 -16.85 
Right Parietal Sub-Gyral 1264 3.29 -5.90 -7.62 
Right Limbic Parahipocampal 1160 3.58 -6.78 -9.92 
Right Frontal Precentral 1056 3.83 -9.46 -12.62 
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Table 3: Clusters found with significant increases in perfusion from pre-
stimulation at day 1 to day 3. All clusters were located outside of the brain. ∆CBF 
represents the increase from day 1 to day 3. 
Volume  (mm3) Max t-statistic 
Average ∆ CBF 
(ml/100g/min) 
Max ∆ CBF 
(ml/100g/min) 
1776 4.87 14.12 9.23 
1312 4.57 11.66 7.69 














 The cluster with statistical significance averaged from across all subjects for day 3 
minus day 2 (negative, 3<2) can be seen in Figure 13. The inverse positive change can be 
seen in Figure 14.  ∆CBF maps masked by significant clusters from Figure 13 & 14 can 
be seen in Figures 15 & 16 respectively averaged from across all 13 subjects. 
 
Figure 13 – Clusters with significant decreased perfusion from day 2 to day 3 




Figure 14 – Clusters with significant increased perfusion from day 2 to day 3 







Figure 15 – Average decrease in CBF from day 2 to day 3 (displayed as day 3 





Figure 16 – Average increase in CBF from day 2 to day 3 (displayed as day 3 
minus day 2) for the significant voxels identified in Figure 14 averaged from all 13 
subjects.  
 For the clusters found with significant decrease in perfusion from day 2 to day 3 
(displayed as day 3 minus day 2), none of which had a size greater than 1.00 cm3. For the 
positive inverse difference, the largest cluster appeared outside the brain and had a 
volume of 3.03 cm3. Table 4 indicates the location and size of significant clusters located 
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(with none smaller than a size of 1.00 cm3) with an increase in perfusion from day 2 to 
day 3. None of the significant clusters found in this table were located within the brain. 
Remaining clusters found in the brain with a size greater than 100mm3 are supplied in 
Appendix A 
Table 4: Clusters found with significant increases in perfusion from pre-
stimulation at day 2 to day 3. All clusters were located outside of the brain. ∆CBF 
is the increase from day 2 to day 3 and was computed as day 3 minus day 2. 
 
Volume  (mm3) Max t-statistic 
 
Average ∆ CBF 
(ml/100g/min) 
 
Max ∆ CBF 
(ml/100g/min) 
3032 5.17 12.8 8.85 
2800 4.64 17.3 11.08 
2704 5.29 7.95 5.46 
1392 4.83 10.7 6.31 
1360 4.4 9.77 6.85 
1232 5.85 21.2 13.62 
1224 5.14 13.5 9.46 
1152 4.05 11.7 8.69 







 The goal of this work was to determine whether the pCASL technique could be 
reliably used to quantify CBF measurements between sessions 24-hours and 48-hours 
apart. ASL is the only MRI method capable of measuring CBF values without the use of 
radioactive tracers in a completely non-invasive manner. Of the three types of ASL: 
pulsed (PASL), continuous (CASL) and pseudocontinuous (pCASL); the pCASL method 
is currently defined as the clinical standard (Alsop et al., 2015) and is commonly 
available in commercial MRI. It is the newest of the three techniques and is not as 
extensively studied as the PASL. While many potential artifacts can appear during 
scanning, such as vascular artifacts, hyper- and hypo-perfusion artifacts, magnetic 
susceptibility artifacts, and especially motion artifacts (Petcharunpaisan, 2010); there are 
many techniques to identify and reduce artifacts in order to produce a clearer image (J. C. 
Ferré et al., 2013).  
 ASL is hardly ever used in any parts of the human body other than the brain. It is 
primarily taken advantage of by researchers in neurological studies. Clinically, this 
technique is used in diagnosing and monitoring various cases such as cerebrovascular 
diseases, acute stroke, brain tumor patients by specifying tumor grade, dementia, 
cognitive disorders and more (Petcharunpaisan, 2010). Similar traditional imaging 
methods such as PET and DSC MRI perfusion imaging have shown comparable results to 
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ASL; though, both of which require injection of harmful tracers with larger risk of harm 
to patients.  
 Several studies have examined the reliability of different forms of ASL in the 
past.  One study (Wang et al., 2011) examined the reproducibility of the PASL technique. 
Ten healthy adult subjects (mean age = 27 ± 8 years, 5 males & 5 females) were scanned 
twice, one week apart. Scanning was done on a 3 tesla whole body MR scanner with a 12 
channel head coil. When it came to data analysis, this study utilized regional CBF (rCBF) 
averages rather than voxel wise comparisons. Regional ASL CBF maps are not typically 
used in clinical settings, thus diminishing the use of the data collected from such studies 
for clinical applications. Comparing their own data to previous reports, this study 
concluded good inter-session reliability and even better intra-session reliability of MRI 
perfusion using the PASL method. Another study took a very similar approach but 
instead evaluated the regional reproducibility of the CASL technique (Gevers et al., 
2009). They had ten healthy subjects with comparable ages and used similar imaging 
equipment. However, there was variation in the separation between the two sessions. 
Subjects returned anytime within a 3-week period. This study concluded that there was 
considerable regional variability between scans but inferred these variations were from 
physiological variations and not the scanning sequence. The regional variability patterns 
they found showed that the variability between sessions was mostly found around brain-
feeding vasculature which mostly reflects differing neuronal activity between subjects. 
Ultimately, the study concluded CASL scanning is able to create steady and reproducible 
CBF values that can be used in clinical routine practice.  
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 Wen-Chau Wu and colleagues completed a similar study testing the 
reproducibility of pCASL perfusion MRI in the human brain (Wu et al., 2011). The 
researchers conducted imaging on a group of 12 healthy volunteers (4 females | 8 males, 
age 22-34 years). This study’s ultimate goal was to compare the reproducibility of 
pCASL to the PASL method. Each subject had two duplicate sessions set 14-days apart 
each at the same time of day as the previous in order to reduce variability. They 
conducted custom, non-clinical processing of the data in order to evaluate said 
comparisons. Again, this diminished the applicability of the reproducibility data in 
clinical settings. The researchers determined both the pCASL and PASL methods had 
good reproducibility within a 2-week period and further quantitative comparisons must 
be conducted to determine the superior technique. Another study compared the CASL, 
PASL, and pCASL techniques in a similar experimental design (Y. Chen et al., 2011). 
Again, a custom data analysis pipeline was implemented reducing its use in a clinical 
setting. Bothe studies conducted a regional analysis of perfusion in the brain rather than a 
voxel based analysis, which is what is used in clinical settings. This study concluded that 
the pCASL technique showed excellent reproducibility that surpasses the CASL and 
PASL methods. Yet another more recent study (Fazlollahi et al., 2015) tested the 
reproducibility of the pCASL technique on 12 healthy subjects with two identical 
sessions just 24-hours apart. However, this study specifically tested the multiphase 
pCASL (MP-pCASL) technique, a newer variant that has slightly improved CBF 
reliability in comparison to the traditional pCASL method but has not been clinically 
adopted (Jung, Wong, & Liu, 2010). Researchers of this study concluded the MP-pCASL 
technique can be used reliably between sessions of 24-hour periods. They also concluded 
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that this method would produce higher reliability compared to the pCASL method as MP-
pCASL has a higher SNR. 
 Based on previous works, we hypothesize that the pCASL technique can be used 
as a reliable method to quantify CBF measurements over a 24-hour and 48-hour period. 
In order to test this, we selected a group of fifteen healthy active duty Air Force Military 
personnel from the sham group of a larger study. Of the 15 subjects scanned on day 1 and 
day 2, 2 of which did not return for scanning on the third day. The subjects completed 
multiple imaging sessions on three consecutive days. We utilized the data from the first 
session of all three days. Imaging took place at the same time in the evening of each days 
to reduce variability. As subjects were military personnel, they followed the same strict 
schedule on all days involved in the study. Subjects of the experimental group of the 
larger study were given a 2mA transcranial stimulation for a duration of 30 minutes, and 
subjects from the sham group were only given said stimulation for 30 seconds. Also, we 
only used the baseline images acquired with the pCASL method before each day’s 
stimulation for our study. This may have caused a placebo effect on patients in the second 
and third day’s scans even though images were acquired at baseline. The CBF maps 
produced from each day were transferred from the 3T MRI machine and processed using 
FSL. Using the FSL Randomise function, we performed a one-sample t-test and 
permutation testing using 215 (32,768) random permutations for the difference between 
day 1 and day 2 and 213 (8192) random permutations for the difference between day 1 
and day 3 and day 2 and day 3. 
  Our findings suggest there are small, systematic variations in measurements of 
CBF quantified by pCASL at least within a 24-hour period. However, the appearance of 
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the relatively small, scattered clusters is more suggestive of noise, motion artifacts or 
other ASL specific artifacts, and/or registration errors rather than systematic variability in 
the quantification of CBF. Furthermore, a placebo effect resulting in altered CBF from 
the day 2 scans from the sham electrical stimulation is also a possibility.  
 Another indication that the slight variations in CBF between days is not a result 
from systematic error is the observation that over half of all significant clusters found in 
the CBF maps from day 1 to day 2 changes and all of the clusters found from the changes 
of day 2 to day 3 were outside of any actual brain matter. This can be seen Figure 5 and 
Figure 13 by simply viewing the cluster locations on the CBF maps. This is also indicated 
in Table 1 and Table 4, where blank spaces in the chart indicate clusters located outside 
of the brain. Clusters outside the skull have no information that can change cluster 
outcomes (Baumgartner, Gautsch, Böhm, & Felber, 2005). This diminishes the 
importance of the significant clusters found and leads us to believe that the changes in 
CBF are simply occurring from an outside source. The largest cluster within the brain 
appeared in the left superior temporal gyrus with a volume of 2.33 cm3. This cluster 
occurred from a decrease in perfusion from day 1 to day 2 most likely due to the subjects 
becoming acclimated to the loud sounds made by the MRI machine during scanning. Our 
data was not corrected for family wise error and we had a conservative cluster threshold 
value of 2.3. 
 Measurements of CBF quantified by pCASL within a 48-hour period, the 
difference between day 1 and day 3, showed much larger clusters in the CBF maps. The 
three clusters significantly larger than the rest appeared within the brain. The largest 
appeared in the left lingual gyrus of the occipital lobe with a volume of 15.45 cm3. The 
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other two appeared in the left superior temporal gyrus and the right insula and had sizes 
of 14.06 cm3 and 12.54 cm3 respectively. These larger changes could be in part caused by 
the added placebo effect from across all three days caused by the sham tDCS. These 
changes could just simply be systemic variation in subjects between days. Also the 
subjects were military personnel who are used to working on a consistent schedule which 
we altered by bringing them to scan until as late as 11pm. The added stress and fatigue by 
the third day may have potentially altered their brain function during scanning. Our scans 
were run for a long duration of about 80-minutes as they were part of a larger study, and 
this adds another factor of fatigue and discomfort. The cluster caused by the decrease in 
perfusion in the occipital lobe may have occurred due to the subjects becoming adjusted 
to the light in the MRI machine by their third session. The insula is thought to play a role 
in emotional processing (Namkung, Kim, & Sawa, 2017), and thus the significant 
decrease in perfusion to this area was most likely caused by the subjects no longer fearing 
or being apprehensive about being in the MRI machine. Again, the large cluster found in 
the superior temporal lobe was most probably due to subjects being acclimated to the 
loud noises the MRI machine produces during scanning.  
 Our work concludes CBF measurements quantified by a non-invasive pCASL 
MRI technique measured within a 24-hour and 48-hour period can be utilized for 
radiologic evaluation. Further evaluation with perhaps a modified experimental design is 
needed to conclude true reliability for a 48-hour period in patients with neurological 
conditions that effect the temporal region of the brain. The majority of the differences 
seen between day 1 and day 2 were eliminated in the scans done between day 2 and day 
3. This would lead us to believe that day 1 is what is causing the significant changes. 
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Thus, for future longitudinal studies testing reliability, there should be several days to 
acquire baseline scans in order to remove the potential effects of the new environment the 
MRI machine may presents.  
  The pCASL technique has the potential to become the standard for brain 
perfusion imaging in clinical settings replacing other invasive methods such as PET 
scanning. The pCASL method is a very important tool to a wide array of clinical 
professionals such as; neuro-radiologist in their everyday imaging, neuro-oncologists in 
tracking brain tumors, neurosurgeons in locating oncogenic brain tissue and neurologists 
in evaluating or locating a wide array of neurological disorders. Future studies should 
continue to test the inter-session reliability of pCASL in longer and varying periods of 
time such as 1, 3 or even 6-month periods. For example, there are no current studies 
found that test pCASL’s reliability over a period longer than 3-weeks.  A study testing 
the pCASL method’s inter-session reliability over a period of 3-months could be very 
useful to neurologists conducting continuous routine checkups on benign brain tumors. 
Time of day during scanning is a factor that should be taken into account in future studies 
as well. All of our scanning took place at night, and this may have effected subjects brain 
activity. Also, we may need to test if reliability is dependent on taking scans at the same 
time of day. If not, future clinical imaging protocols would need to be altered in order to 
ensure patients are returning to be scanned at the same time as previous scanning. Finally, 
future studies may be better off only scanning for ASL when testing its reliability. ASL 
scans separately only last approximately 11-minutes total compared to the 80-minutes of 
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VI. Appendix A 
 
Table 5 – Below are the 49 clusters larger than 100mm3 that were found within the brain 
for the decrease in perfusion from day 1 to day 2. We found 204 clusters within the brain 
with a size smaller than 100mm3 for the same day difference. No clusters larger than 

























291 3.65 71 45 42 73.7 43.5 39.1 
236 3.53 46 17 33 43.9 18.5 33.7 
199 3.46 22 65 31 21.6 66.9 35.9 
134 3.2 57 21 31 57.8 19.4 27.2 
113 3.22 46 24 50 47.4 23.9 50.9 
100 3.3 29 39 35 27.2 41.5 27.7 
97 3.49 16 53 38 16 53 42.6 
94 3.55 41 63 35 40.7 62.9 32.6 
88 4.67 54 66 13 54.6 65.6 16.2 
78 3.04 65 56 33 65.7 57.3 32.4 
68 2.85 50 66 67 50.4 65.4 66.9 
63 3.13 25 74 40 25 73.1 35.6 
56 3.3 74 51 39 73.8 50.6 39.3 
54 3.1 71 46 30 71.4 46.4 28.6 
50 3.2 42 65 68 41.7 64.9 68.8 
49 3.12 60 52 71 61 52.6 66.5 
42 4.2 48 75 22 47.3 78.5 21.8 
42 3.41 73 61 17 72.3 62.4 18.1 
41 3.73 64 44 13 63 43.1 13.4 
40 3.3 64 49 25 64.1 49 25 
39 3.38 35 44 29 35.5 43.1 28.9 
53 
 
37 2.88 37 20 48 35.3 21.1 50.4 
36 3.02 65 32 16 65.6 33 16.8 
32 3.35 50 84 57 50.4 84.5 57.5 
28 2.75 47 61 68 47.2 60.9 68.5 
25 3.02 20 64 61 20.1 63.3 59.6 
23 2.76 26 48 46 24.4 47.5 44.9 
21 3.71 42 75 22 42.1 74.6 22.9 
21 2.88 60 23 45 59.3 22.8 44.5 
19 2.5 64 55 55 63.8 55.9 55.8 
18 3.01 59 37 29 58.7 37.4 29.8 
18 2.76 62 33 8 62.2 33.5 7.61 
17 2.87 69 27 25 68.3 26.6 26.5 
17 2.81 35 43 34 35.2 42.7 34.3 
16 2.81 49 61 39 49.5 60.6 38.2 
16 2.75 53 27 9 53 26.8 8.87 
16 2.65 54 22 47 53.9 22.1 48.6 
15 2.91 48 28 28 47.6 26.6 27.2 
15 2.87 17 46 32 16.9 45.9 31.7 
15 2.68 20 58 31 19.7 58.9 31.9 
15 2.5 56 33 19 56.3 33.5 20.9 
15 3.11 49 63 52 49.5 62.7 52.4 
14 2.7 25 59 57 25.6 59.2 56.4 
14 2.63 38 34 10 38.1 33.2 9.22 
13 2.73 64 40 34 64.3 41.2 34.5 
13 3.01 67 70 20 66.8 70.5 20.4 
13 3 75 30 45 75.7 32.2 42.3 
13 3.22 40 80 60 39.8 80.2 59.6 
 
Table 6 – Below are the 40 clusters larger than 100mm3 that were found within the brain 
for the decrease in perfusion from day 1 to day 3. We found 156 clusters within the brain 
























83 3.27 70 61 27 69.8 61.6 32.2 
64 3.12 31 81 30 28 80.5 28 
59 3.61 42 72 66 42.5 70.9 64.1 
54 
 
52 3.01 65 62 56 64.6 62.3 56.7 
51 3.54 13 52 39 12.3 53.2 37.9 
50 3.73 54 51 27 54 50.6 27.6 
48 3.39 55 49 40 54.3 48.2 38.5 
46 3.34 27 77 36 25 76 36.5 
45 3 31 32 36 31.2 34.2 38 
45 3.57 47 53 58 46.6 53.5 58.3 
41 3.48 33 74 24 33.6 74 24.9 
40 3.02 18 44 48 18.5 44.7 48.8 
37 2.95 23 40 46 22.5 40.5 48.5 
32 3.28 34 68 12 33.3 68.1 14.1 
31 2.92 72 70 41 72.4 71.4 37.7 
30 3.4 43 88 41 43 87.4 40.8 
30 2.94 36 80 53 33.8 80.1 53.5 
30 3.15 44 86 34 43.7 85.6 33.5 
28 2.76 18 62 18 18.3 62.3 18.4 
27 2.98 22 51 49 21.1 50.4 48.5 
24 2.7 62 33 25 61.8 32 23 
22 2.95 21 79 51 21.7 79 50.4 
20 3.01 41 71 38 40.6 71.5 37.9 
19 2.85 68 75 46 67.4 74.9 45.4 
19 2.85 36 90 53 36.9 90.4 51.2 
18 3 61 78 51 61.1 77.8 50.4 
17 2.65 27 64 59 27.2 63.7 60.7 
17 3.05 45 87 49 44.6 86.8 48.7 
16 3.04 26 39 35 26.3 38.6 35.4 
16 3.96 46 15 46 46.7 15.1 46.2 
16 2.85 42 69 24 42 68.4 25 
15 2.81 23 30 52 23.8 29.3 50 
15 2.64 37 62 67 36.7 62.7 68.6 
15 2.78 34 67 61 34.1 67 61 
15 2.7 61 67 12 60.7 67.9 14 
14 2.6 44 36 19 44.3 35.7 19.6 
14 2.77 48 53 41 47.7 53.2 41 
14 2.85 47 37 8 46.5 36.5 7.09 
13 2.59 59 82 32 59.3 81.6 31.4 





Table 7 – Below is the 1 cluster larger than 100mm3 that was found within the brain for 
the increase in perfusion from day 1 to day 3. We found 31 clusters within the brain with 
























20 3.33 45 47 40 45.3 47.2 41.3 
 
Table 8 – Below are the 41 clusters larger than 100mm3 that were found within the brain 
for the decrease in perfusion from day 2 to day 3. We found 158 clusters within the brain 
























83 3.27 70 61 27 69.8 61.6 32.2 
64 3.12 31 81 30 28 80.5 28 
59 3.61 42 72 66 42.5 70.9 64.1 
52 3.01 65 62 56 64.6 62.3 56.7 
51 3.54 13 52 39 12.3 53.2 37.9 
50 3.73 54 51 27 54 50.6 27.6 
48 3.39 55 49 40 54.3 48.2 38.5 
46 3.34 27 77 36 25 76 36.5 
45 3 31 32 36 31.2 34.2 38 
45 3.57 47 53 58 46.6 53.5 58.3 
41 3.48 33 74 24 33.6 74 24.9 
40 3.02 18 44 48 18.5 44.7 48.8 
37 2.95 23 40 46 22.5 40.5 48.5 
32 3.28 34 68 12 33.3 68.1 14.1 
31 2.92 72 70 41 72.4 71.4 37.7 
30 3.4 43 88 41 43 87.4 40.8 
30 2.94 36 80 53 33.8 80.1 53.5 
30 3.15 44 86 34 43.7 85.6 33.5 
28 2.76 18 62 18 18.3 62.3 18.4 
56 
 
27 2.98 22 51 49 21.1 50.4 48.5 
24 2.7 62 33 25 61.8 32 23 
22 2.95 21 79 51 21.7 79 50.4 
20 3.01 41 71 38 40.6 71.5 37.9 
19 2.85 68 75 46 67.4 74.9 45.4 
19 2.85 36 90 53 36.9 90.4 51.2 
18 3 61 78 51 61.1 77.8 50.4 
17 2.65 27 64 59 27.2 63.7 60.7 
17 3.05 45 87 49 44.6 86.8 48.7 
16 3.04 26 39 35 26.3 38.6 35.4 
16 3.96 46 15 46 46.7 15.1 46.2 
16 2.85 42 69 24 42 68.4 25 
15 2.81 23 30 52 23.8 29.3 50 
15 2.64 37 62 67 36.7 62.7 68.6 
15 2.78 34 67 61 34.1 67 61 
15 2.7 61 67 12 60.7 67.9 14 
14 2.6 44 36 19 44.3 35.7 19.6 
14 2.77 48 53 41 47.7 53.2 41 
14 2.85 47 37 8 46.5 36.5 7.09 
13 2.59 59 82 32 59.3 81.6 31.4 
13 2.72 41 37 3 40.3 38.1 3.75 
 
Table 9 – Below are the 3 clusters larger than 100mm3 that were found within the brain 
for the increase in perfusion from day 2 to day 3. We found 87 clusters within the brain 
























32 3.81 48 57 30 48 56.9 29.6 
16 3.9 65 44 14 64.7 43.2 12.7 
13 3.09 38 55 52 37.6 54.8 51.5 
 
